Medicine, not food, may have more to gain from cloning
By Rick Barrett,
Milwaukee Journal Sentinel
| 08. 14. 2010
[Quoting CGS's Pete Shanks]
The cloning of animals may have come from agriculture, but its real promise may be in the lucrative field of medicine rather than as food.
Genetically modified cows and goats can produce proteins in their milk that can be extracted as a drug component. Cloning animals to create living drug factories could lower the costs of medicines used to save lives.
Examples include cows that pump pharmaceutical proteins and antibodies in their milk and blood; chickens that lay drug-producing eggs; and pigs that grow human-ready organs. Making perfect copies of these animals, through cloning, could speed up the drug-making process, according to scientists.
"Once you create a genetically engineered animal, you want to make copies," said David Andrews, director of animal biotechnology at the Biotechnology Industry Organization, a trade association that represents 1,200 companies.
In Dane County, a now-closed biotech firm created cloned pigs that had human-friendly, transplantable organs.
The same firm, Infigen, created a herd of cloned cows with drug-making capabilities.
Infigen wanted to produce proteins for the treatment of hemophilia, an affliction that causes uncontrolled bleeding, and Pompe's...
Related Articles
By Isaac Schultz, Gizmodo | 10.18.2024
Colossal Biosciences, a company mainly known for intending to genetically engineer proxies for several iconic extinct species, announced this week that it has made major steps towards the de-extinction of the thylacine, or Tasmanian tiger.
The thylacine was a carnivorous...
By Russ Burlingame, Comicbook | 07.23.2024
Colossal Laboratories and Biosciences, a biotech company that's putting together plans to orchestrate the de-extinction for animals like the dodo and the wooly mammoth, made some waves on Reddit recently when they petitioned the United Federation of Planets -- the...
By Shelly Fan, Singularity Hub | 05.31.2024
We all know the drill for reproduction—sperm meets egg.
For the past decade, scientists have been pushing the boundaries of where the two halves come from. Thanks to induced pluripotent stem cell technology, it’s now possible to scrape skin cells...
By Alison Snyder, Axios | 06.06.2024
Gene editing's next chapter will be focused on tackling cancers and more common diseases, uncovering new details about aging and other fundamental aspects of biology and editing RNA, top scientists in the field said this week.
The big picture: ...